Shareholders' equity · 2018–2025
Pharming Group shareholders' equity
$277M+25.4% · FY2025
Pharming Group (PHAR) reported $277M in shareholders' equity for fiscal 2025, +25.4% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $277M | +25.4% | Open → |
| FY20242024-12-31 | $221M | +1.0% | Open → |
| FY20232023-12-31 | $219M | +6.9% | Open → |
| FY20222022-12-31 | $205M | +6.1% | Open → |
| FY20212021-12-31 | $193M | +5.2% | Open → |
| FY20202020-12-31 | $183M | +56.3% | Open → |
| FY20192019-12-31 | $117M | +83.1% | Open → |
| FY20182018-12-31 | $64.1M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +23.3%
Figures are reported under IFRS, in US dollars.
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Pharming Group shareholders' equity |url=https://companiesranked.com/en/company/pharming-group/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Pharming Group shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/pharming-group/shareholders-equityBibTeX
@misc{companiesranked-en-company-pharming-group-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Pharming Group shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/pharming-group/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001828316-26-000015 · April 2, 2026
{{cite web |title=Pharming Group shareholders' equity — 20-F (0001828316-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1828316/000182831626000015/pharm-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-04-02}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.